DESCRIPTION Source: E. coliderived Accession: P19731 N-terminal Sequence Analysis Ala2 Predicted Molecular Mass 20.9 kDa SPECIFICATIONS SDS- PAGE 20.9 kDa, reducing conditions. Activity Measured by its ability to agglutinate human red blood cells. Hadari, Y.R. et al.(2000) J. Cell Sci. 113:2385. The ED50 for this effect is 3 10 µg/mL. Purity ≥ 96% by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. Formulation Supplied as a 0.2 μm filtered solution in PBS, pH 7.4,5%Glycerol Endotoxin Level <0.10 EU per 1 μg of the protein by the LAL method. PREPARATION AND STORAGE Shipping : The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: 12 months from date of receipt, -20 to -80 °C as supplied. 3 months, 2 to 8 °C under sterile conditions ACTIVITY ASSAY PROTOCOL DATA Bioactivity and SDS-PAGEBioactivity was measured by its ability to agglutinate human red blood cells. Hadari, Y.R. et al. (2000) J. Cell Sci. 113:2385. The ED50 for this effect is 3 10 µg/mL.Purity was measured by SDS-PAGE Sandwich ELISA:Dilution curves of recombinant human galectin 3 (XJ-Ag-01) in sandwich ELISA.using 11L24 as the capture antibody and 9K21 as the detection antibody.Signal decreased as the recombinant human galectin 3(XJ-Ag-01) dilution increased.
BACKGROUND
lGalectin-3 (Gal-3) is also known as LGALS3, It is the only chimera member
of the Galectins family. It is formed by cross-linking a glycosyl with a
non-glycosyl ligand. Gal-3 includes 3 binding domains, NH2 terminal binding
domain, 1 sugar structure recognition domain and 1 A unique domain rich in
glycine and proline repeats. LGALS3 / Galectin-3 is expressed in the nucleus,
cytoplasm, mitochondrion, cell surface, and extracellular space. LGALS3 /
Galectin-3 has been shown to be involved in the following biological processes:
cell adhesion, cell activation and chemoattraction, cell growth and
differentiation, cellcycle, and apoptosis. Galectin 3 is involved in
regulating cell growth, anti-apoptosis, mediating cell adhesion, and
participating in biological functions such as blood vessel formation and inflammation. Studies have shown that Galectin-3 is a marker of myocardial fibrosis and is associated with the occurrence of heart failure and an increased risk of death. The content of galectin-3 in patients with ventricular dysfunction will increase, and the content is directly related to the severity of heart failure.
References
1.Lakomkin SV, Skvortsov AA, Goriunova TV, et al. Galectin 3--a new biomarker for diagnostics and outcome of chronic heart failure [J]. Kardiologiia, 2012, 52(3): 45-52. 2.Galectin-3: a novel mediator of heart failure development and progression. R A. de Boer et al., European Journal of Heart Failure (2009) 11; 811–817 . 3.Gruson D, Lepoutre T, Ahn SA, et al. Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure [J]. Clin Biochem, 2013, 46(4-5): 391-394. DOI: 10.1016/j.clinbiochem.2012.12.002.